The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
BHRD aligns very nicely with Martin sorrels digital ambitions and it's super cheap
Peter Scott is on record some time ago lamenting the poor performance of the share price god only knows how he feels now
Other than a buy out I'm not sure how peter Scott is going to get a decent pay day
Some of the key investors and advisors are also in Derriston Capital
And another drop today so far..........
I've got September penciled in for news (if not before)
Intersting regards S4 link and the demise in the SP, MM’s playing their games?
Nice if it happens,but remember this is AIM after all.
Probably the biggest money drainer next to the horses.
Sometimes best to stay with the 100 index.
That's where I seem to gain most.
GL to all holders. Inc myself.
Ty for your observations
2.88P takeover is fine if buying this low.
Interesting read on uk investor article Bhrd certainly appears to be vulnerable to a takeover at the current low share price although personally 2.88 a share would still leave me underwater
I have emailed investor relations about the current situation and am awaiting a response
Rumours of a takeover have been around for a while but the current opportunity may make it more likely I guess
" Some are speculating that S4’s next acquisition could be Be Heard Group plc,"
constant selling so, even with buys they push the sp down... must be a tr1 in the next day or two to explain it... maybe then it'lll be possible to assess fair sp...
gla.
rise to day
This does not feel right does anyone have any theory on what is happening to this share.
Goes someway to explain the drop
some big offload
105k and 135k
True
revenue can grow by a billion%... net profit is the numbers to be looking at...
but there's no way it's now only worth a third what it was in 2017 (one would think)... but that sp ain;t moving so there must still be sellers in the background. no way ot telling how many shares left...
Highlights
· Group revenues in excess of £14 million, +70% vs Last Year.
· Like for like revenue growth of 15%.
· Notable wins from Aviva, GSK, blu, and Equifax.
· Be Heard converting new business as a Group alongside individual company successes.
· EBITDA guidance adjusted to reflect investment in business development, service capacity and provision for client spend volatility.
· Cost reductions implemented to support investment and underpin H2 2018 and 2019.
· Latest industry estimates suggest an uptick in UK marketing and advertising expenditure in H2. Digital continues to drive market growth.
The Group recorded strong overall growth in revenues and +15 per cent on a pro-forma basis, in the six months ended 30 June 2018. This was driven by notable client gains and increased spend from existing client relationships. Wins such as Aviva, GSK, blu and Equifax were secured against major competitors, reflecting demand for our integrated, end-to-end model. This growth has been particularly encouraging when set against a backdrop of rising economic uncertainty and a resultant slowdown in marketing activity.
this could be the bottom
Bought a load .oversold
50% down on january... more on september... all it'll take is some news about kicking out the unproductive clients and this'll fly... whether that news comes or not is another matter... but you'd be hard to find anyone on here who could tell you what is fair value (beyond 'less than it is now')
gla...
buys cominy in now
nice 10k buy
at the moment there's a bit of a buying flurry... but it ain't moving the share up the way the same trades moved it down yesterday.
could mean that there are still a lot of shares to get rid of still... suprised there's no tr1 yet...
parked now at 1.09... we'll see which way it goes now, if at all. what we do know is that the share's now down about 50% and folk are well aware of it... if it jumps back more than 5% it could pick up momentum of its own,,,
whether it'd be a p + d or an oversold share, be worth keeping an eye on it this morning.
gla...